• Publications
  • The Methodology for the 2021 Antimicrobial Re...
Published on 06 Oct 2020

The Methodology for the 2021 Antimicrobial Resistance Benchmark

The Antimicrobial Resistance Benchmark provides the only independent measure of how pharmaceutical companies are responding to treatment-resistant bacterial and fungal diseases. The methodology for the 2021 report enables the tracking of pharma's progress against superbugs and a deeper exploration of the headwinds faced by biotechs driving novel R&D.

Explore further

Get in touch

Back to top |